Report overview
Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Proteins and Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Proteins and Oral Vaccines. This report contains market size and forecasts of Therapeutic Proteins and Oral Vaccines in global, including the following market information:
Global Therapeutic Proteins and Oral Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Therapeutic Proteins and Oral Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Therapeutic Proteins Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Proteins and Oral Vaccines include Abbott, Amgen, Biogen, Eli Lilly and Company, Roche, Johnson and Johnson, Merck, Novo Nordisk and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Proteins and Oral Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Proteins and Oral Vaccines Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, by Type, 2022 (%)
Therapeutic Proteins
Oral Vaccines
Global Therapeutic Proteins and Oral Vaccines Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Therapeutic Proteins and Oral Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Proteins and Oral Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Therapeutic Proteins and Oral Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Proteins and Oral Vaccines, market overview.
Chapter 2: Global Therapeutic Proteins and Oral Vaccines market size in revenue.
Chapter 3: Detailed analysis of Therapeutic Proteins and Oral Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Proteins and Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
